Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT - Merit Medical Systems, Inc. (MMSI) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 3, 2020


NEW YORK, Dec. 6, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Merit Medical Systems, Inc. ("Merit"  or the Company") (NASDAQ: MMSI) and certain of its officers, on behalf of shareholders who purchased Merit securities between February 26, 2019 and October 30, 2019, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/mmsi.  

Bronstein, Gewirtz & Grossman, LLC

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (2) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (3) in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis. 

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/mmsi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Merit you have until February 3, 2020 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

 

SOURCE Bronstein, Gewirtz & Grossman, LLC


These press releases may also interest you

at 12:55
Institute for Supply Management® (ISM®) has selected the 2024 recipients of the R. Gene Richter Scholarship, an award presented annually to the top supply management students from across the United States. Recipients were determined based upon a...

at 12:55
BAE Systems (LON: BA) received a $754 million contract award to continue producing the Armored Multi-Purpose Vehicle (AMPV) family of vehicles (FoVs) for the U.S. Army. This contract begins the second phase of full-rate production of AMPVs between...

at 12:50
Scotiabank is pleased to announce it will be recognized on The Globe and Mail's 2024 Report on Business magazine's annual Women Lead Here list for the fourth consecutive year. This annual editorial benchmark identifies top-level Canadian businesses...

at 12:47
"We are profoundly saddened at the passing of our firm's senior counsel Senator Joe Lieberman. We were honored when this great statesman joined our firm when he retired from the Senate over ten years ago. We are grateful for his many contributions to...

at 12:46
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...

at 12:46
Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today a milestone for its iTindtm device with its availability and greater patient access through the largest healthcare group...



News published on and distributed by: